129 related articles for article (PubMed ID: 37861356)
1. Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance-mediated oxaliplatin chemoresistance in colorectal cancer.
Xu Y; Hao J; Chen Q; Qin Y; Qin H; Ren S; Sun C; Zhu Y; Shao B; Zhang J; Wang H
Mol Carcinog; 2024 Feb; 63(2):224-237. PubMed ID: 37861356
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
[TBL] [Abstract][Full Text] [Related]
3. SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.
Li SQ; Xu WT; Yin YX; Wei HT; Li KZ; Xie MZ; Lv F; Xie LY; Hu BL
Apoptosis; 2024 Jun; 29(5-6):835-848. PubMed ID: 38573492
[TBL] [Abstract][Full Text] [Related]
4. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11.
Zhang W; Sun Y; Bai L; Zhi L; Yang Y; Zhao Q; Chen C; Qi Y; Gao W; He W; Wang L; Chen D; Fan S; Chen H; Piao HL; Qiao Q; Xu Z; Zhang J; Zhao J; Zhang S; Yin Y; Peng C; Li X; Liu Q; Liu H; Wang Y
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34609966
[TBL] [Abstract][Full Text] [Related]
5. Suppressing circIDE/miR-19b-3p/RBMS1 axis exhibits promoting-tumour activity through upregulating GPX4 to diminish ferroptosis in hepatocellular carcinoma.
Zhai H; Zhong S; Wu R; Mo Z; Zheng S; Xue J; Meng H; Liu M; Chen X; Zhang G; Zheng X; Du F; Li R; Zhou B
Epigenetics; 2023 Dec; 18(1):2192438. PubMed ID: 36989117
[TBL] [Abstract][Full Text] [Related]
6. Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer.
Zhang Q; Deng T; Zhang H; Zuo D; Zhu Q; Bai M; Liu R; Ning T; Zhang L; Yu Z; Zhang H; Ba Y
Adv Sci (Weinh); 2022 Oct; 9(28):e2203357. PubMed ID: 35978266
[TBL] [Abstract][Full Text] [Related]
7. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
8. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
Yang C; Zhang Y; Lin S; Liu Y; Li W
Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer.
Zeng K; Li W; Wang Y; Zhang Z; Zhang L; Zhang W; Xing Y; Zhou C
Adv Sci (Weinh); 2023 Sep; 10(25):e2301088. PubMed ID: 37428466
[TBL] [Abstract][Full Text] [Related]
10. Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis.
Shao L; Zhu L; Su R; Yang C; Gao X; Xu Y; Wang H; Guo C; Li H
Sci Rep; 2024 May; 14(1):10745. PubMed ID: 38730240
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
[TBL] [Abstract][Full Text] [Related]
12. The AKT/GSK3-Mediated Slug Expression Contributes to Oxaliplatin Resistance in Colorectal Cancer via Upregulation of ERCC1.
Wei W; Ma XD; Jiang GM; Shi B; Zhong W; Sun CL; Zhao L; Hou YJ; Wang H
Oncol Res; 2020 Sep; 28(4):423-438. PubMed ID: 32331534
[TBL] [Abstract][Full Text] [Related]
13. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
14. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.
Zhang B; Chan SH; Liu XQ; Shi YY; Dong ZX; Shao XR; Zheng LY; Mai ZY; Fang TL; Deng LZ; Zhou DS; Chen SN; Li M; Zhang XD
J Cell Mol Med; 2021 Sep; 25(18):8836-8849. PubMed ID: 34378321
[TBL] [Abstract][Full Text] [Related]
15. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity.
Di Y; Jing X; Hu K; Wen X; Ye L; Zhang X; Qin J; Ye J; Lin R; Wang Z; He W
Drug Resist Updat; 2023 Jan; 66():100909. PubMed ID: 36525936
[TBL] [Abstract][Full Text] [Related]
16. MiR-744 mediates the Oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1.
Zhou Y; He A; Zhang L; Yi G
Neoplasma; 2020 Mar; 67(2):296-303. PubMed ID: 31884801
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
Wang H; Li H; Zhang L; Yang D
Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
[TBL] [Abstract][Full Text] [Related]
18. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
[TBL] [Abstract][Full Text] [Related]
19. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
20. Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer.
Jiang H; Zeng Y; Jiang X; Xu X; Zhao L; Yuan X; Xu J; Zhao M; Wu F; Li G
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167210. PubMed ID: 38704001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
